Cme Group Stock Revenue
| CME Stock | USD 229.03 2.47 1.09% |
CME Group fundamentals help investors to digest information that contributes to CME's financial success or failures. It also enables traders to predict the movement of CME Stock. The fundamental analysis module provides a way to measure CME's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CME stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 5.6 B | 3 B |
CME | Revenue |
CME Group Company Revenue Analysis
CME's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current CME Revenue | 5.58 B |
Most of CME's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CME Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of CME
Projected quarterly revenue analysis of CME Group provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of CME match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in CME's stock price.
CME Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for CME is extremely important. It helps to project a fair market value of CME Stock properly, considering its historical fundamentals such as Revenue. Since CME's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CME's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CME's interrelated accounts and indicators.
| 0.34 | 0.28 | -0.35 | 0.41 | -0.34 | ||
| 0.34 | 0.96 | -0.45 | 0.86 | 0.74 | ||
| 0.28 | 0.96 | -0.31 | 0.84 | 0.72 | ||
| -0.35 | -0.45 | -0.31 | -0.64 | -0.27 | ||
| 0.41 | 0.86 | 0.84 | -0.64 | 0.61 | ||
| -0.34 | 0.74 | 0.72 | -0.27 | 0.61 |
Click cells to compare fundamentals
CME Revenue Historical Pattern
Today, most investors in CME Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CME's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of CME revenue as a starting point in their analysis.
CME Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
CME Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, CME Group reported 5.58 B of revenue. This is 50.23% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The revenue for all United States stocks is 40.87% higher than that of the company.
CME Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CME's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CME could also be used in its relative valuation, which is a method of valuing CME by comparing valuation metrics of similar companies.CME is currently under evaluation in revenue category among its peers.
CME ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CME's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CME's managers, analysts, and investors.Environmental | Governance | Social |
CME Institutional Holders
Institutional Holdings refers to the ownership stake in CME that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of CME's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing CME's value.| Shares | Fidelity International Ltd | 2024-06-30 | 3.9 M | Northern Trust Corp | 2024-09-30 | 3.5 M | Vontobel Holding Ltd. | 2024-06-30 | 3.5 M | Fiera Capital Corporation | 2024-06-30 | 3.3 M | Guardcap Asset Management Limited | 2024-09-30 | 3.3 M | Royal Bank Of Canada | 2024-06-30 | 3.2 M | Mitsubishi Ufj Asset Management Co.,ltd | 2024-09-30 | 3 M | Raymond James & Associates | 2024-09-30 | 2.9 M | Legal & General Group Plc | 2024-06-30 | 2.8 M | Vanguard Group Inc | 2024-09-30 | 33.9 M | Blackrock Inc | 2024-06-30 | 25.7 M |
CME Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0184 | |||
| Profit Margin | 0.57 % | |||
| Operating Margin | 0.65 % | |||
| Current Valuation | 83.16 B | |||
| Shares Outstanding | 360.36 M | |||
| Shares Owned By Insiders | 0.45 % | |||
| Shares Owned By Institutions | 89.29 % | |||
| Number Of Shares Shorted | 3.83 M | |||
| Price To Earning | 32.83 X | |||
| Price To Book | 2.91 X | |||
| Price To Sales | 13.53 X | |||
| Revenue | 5.58 B | |||
| Gross Profit | 5.01 B | |||
| EBITDA | 3.79 B | |||
| Net Income | 3.23 B | |||
| Cash And Equivalents | 2.22 B | |||
| Cash Per Share | 6.19 X | |||
| Total Debt | 3.88 B | |||
| Debt To Equity | 0.12 % | |||
| Current Ratio | 1.02 X | |||
| Book Value Per Share | 78.47 X | |||
| Cash Flow From Operations | 3.45 B | |||
| Short Ratio | 2.39 X | |||
| Earnings Per Share | 9.51 X | |||
| Price To Earnings To Growth | 7.92 X | |||
| Target Price | 235.25 | |||
| Number Of Employees | 3.56 K | |||
| Beta | 0.56 | |||
| Market Capitalization | 81.64 B | |||
| Total Asset | 129.71 B | |||
| Retained Earnings | 4.46 B | |||
| Working Capital | 1.47 B | |||
| Current Asset | 37.9 B | |||
| Current Liabilities | 36.82 B | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.68 % | |||
| Net Asset | 129.71 B | |||
| Last Dividend Paid | 4.55 |
About CME Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CME Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CME using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CME Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:Check out CME Piotroski F Score and CME Altman Z Score analysis. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Financial Exchanges & Data space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.214 | Dividend Share 4.55 | Earnings Share 9.51 | Revenue Per Share 16.795 | Quarterly Revenue Growth 0.185 |
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.